These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Liver support systems: the low clearance of model hepatic excretory anions by charcoal hemoperfusion. Hew JT; Hart FE; Willson RA Gastroenterology; 1978 Apr; 74(4):661-3. PubMed ID: 631502 [TBL] [Abstract][Full Text] [Related]
27. Solute, amino acid, and hormone changes with coated charcoal hemoperfusion in uremia. Winchester JF; Ratcliffe JG; Carlyle E; Kennedy AC Kidney Int; 1978 Jul; 14(1):74-81. PubMed ID: 682427 [TBL] [Abstract][Full Text] [Related]
28. Proceedings: Properties of activated charcoal and dialysis in relation to their use in an artificial liver support system. Gazzard BG; Dunlop EH; Langley PG; Weston MJ; Williams R Clin Sci Mol Med; 1974 Aug; 47(2):3P. PubMed ID: 4415284 [No Abstract] [Full Text] [Related]
29. Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy. Kramer L; Gendo A; Madl C; Ferrara I; Funk G; Schenk P; Sunder-Plassmann G; Hörl WH Am J Kidney Dis; 2000 Dec; 36(6):1193-200. PubMed ID: 11096044 [TBL] [Abstract][Full Text] [Related]
30. [Charcoal-activated hemoperfusion--an important adjunct therapeutic method in severe poisoning]. Voigtmann R; von Baeyer H; Sieberth HG Med Welt; 1976 Apr; 27(16):752-7. PubMed ID: 1272030 [No Abstract] [Full Text] [Related]
32. [Intrahepatic portal arterialization associated with portacaval shunt: a preliminary experimental report]. Dong FZ Zhonghua Wai Ke Za Zhi; 1983 Apr; 21(4):211-6. PubMed ID: 6617376 [No Abstract] [Full Text] [Related]
33. Editorial: Progress with an artificial liver. Lancet; 1974 Oct; 2(7887):992-4. PubMed ID: 4138717 [No Abstract] [Full Text] [Related]
34. [The role of total colectomy in portacaval encephalopathy]. Leger L; Lenriot JP; Fourestier M; Goiffon B J Chir (Paris); 1972; 103(5):437-50. PubMed ID: 4653423 [No Abstract] [Full Text] [Related]
35. Effect of sorbent-based dialytic therapy with the BioLogic-DT on an experimental model of hepatic failure. Ash SR; Carr DJ; Blake DE; Rainier JB; Demetriou AA; Rozga J ASAIO J; 1993; 39(3):M675-80. PubMed ID: 8268623 [TBL] [Abstract][Full Text] [Related]
36. Charcoal hemoperfusion. Plus ça change, plus c'est la même chose. Berk PD; Goldberg JD Gastroenterology; 1988 May; 94(5 Pt 1):1228-30. PubMed ID: 3350293 [No Abstract] [Full Text] [Related]
37. Hepatic coma: newer pathogenetic and therapeutic factors. Steigmann F; Condon RE; Silverman DA; Bombeck CT; Alavi I; Dubin A Am J Gastroenterol; 1970 Oct; 54(4):355-62. PubMed ID: 5478848 [No Abstract] [Full Text] [Related]
38. Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure. Chang TM Kidney Int Suppl; 1975 Feb; (3):387-92. PubMed ID: 1099317 [No Abstract] [Full Text] [Related]
39. Methionine-induced hepatic coma in dogs. Merino GE; Jetzer T; Doizaki WM; Najarian JS Am J Surg; 1975 Jul; 130(1):41-46. PubMed ID: 1155716 [TBL] [Abstract][Full Text] [Related]
40. Precipitation of overt encephalopathy in the portacaval shunted rat: towards the development of an adequate model of chronic portal systemic encephalopathy. Mullen KD; Roessle M; Jones DB; Grun M; Jones EA Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):293-8. PubMed ID: 9096433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]